Skip Header

1 - 25 of 35 results for author:"Stalla G.K." in Literature citations

Page of 2 | Next »

to top of page·  

Results Customize

› Repeat search in UniProtKB (15)

Corticotropin releasing hormone (CRH) response in patients with early rheumatoid arthritis due to polymorphisms in the CRH gene.

Malysheva O., Wagner U., Wahle M., Wagner U., Stalla G.K., Baerwald C.G.

Clin. Exp. Rheumatol. 30:421-423(2012) · Mapped (1)

RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.

Shan B., Gerez J., Haedo M., Fuertes M., Theodoropoulou M., Buchfelder M., Losa M., Stalla G.K., Arzt E., Renner U.

Endocr. Relat. Cancer 19:13-27(2012) · Mapped (19)

High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.

Tichomirowa M.A., Barlier A., Daly A.F., Jaffrain-Rea M.L., Ronchi C., Yaneva M., Urban J.D., Petrossians P., Elenkova A., Tabarin A. et al.

Eur. J. Endocrinol. 165:509-515(2011) · UniProtKB (1) · Mapped (3)

Opposite effects of serum- and glucocorticoid-regulated kinase-1 and glucocorticoids on POMC transcription and ACTH release.

Reiter M.H., Vila G., Knosp E., Baumgartner-Parzer S.M., Wagner L., Stalla G.K., Luger A.

Am. J. Physiol. Endocrinol. Metab. 301:E336-41(2011) · Mapped (8)

All-cause mortality and serum insulin-like growth factor I in primary care patients.

Friedrich N., Schneider H., Dorr M., Nauck M., Volzke H., Klotsche J., Sievers C., Pittrow D., Bohler S., Lehnert H. et al.

Growth Horm. IGF Res. 21:102-106(2011) · Mapped (7)

Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.

Daly A.F., Tichomirowa M.A., Petrossians P., Heliovaara E., Jaffrain-Rea M.L., Barlier A., Naves L.A., Ebeling T., Karhu A., Raappana A. et al.

J. Clin. Endocrinol. Metab. 95:E373-83(2010) · Mapped (4)

Pituitary tumors: cell type-specific roles for BMP-4.

Labeur M., Paez-Pereda M., Haedo M., Arzt E., Stalla G.K.

Mol. Cell. Endocrinol. 326:85-88(2010) · Mapped (2)

ZAC1 target genes and pituitary tumorigenesis.

Theodoropoulou M., Stalla G.K., Spengler D.

Mol. Cell. Endocrinol. 326:60-65(2010) · Mapped (9)

Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.

Meyer S., Schaefer S., Stolk L., Arp P., Uitterlinden A.G., Plockinger U., Stalla G.K., Tuschy U., Weber M.M., Weise A. et al.

Pharmacogenomics 10:1599-1608(2009) · Mapped (4)

NOD2 receptors in adenopituitary folliculostellate cells: expression and function.

Correa-de-Santana E., Frohlich B., Labeur M., Paez-Pereda M., Theodoropoulou M., Monteserin J.L., Renner U., Stalla G.K.

J. Endocrinol. 203:111-122(2009) · Mapped (20)

Differential gene expression in models of pituitary prolactin-producing tumoral cells.

Giacomini D., Haedo M., Gerez J., Druker J., Paez-Pereda M., Labeur M., Stalla G.K., Arzt E.

Horm. Res. 71 Suppl 2:88-94(2009) · Mapped (5)

Platelet-derived growth factor (PDGF) and PDGF receptor expression and function in folliculostellate pituitary cells.

Kowarik M., Onofri C., Colaco T., Stalla G.K., Renner U.

Exp. Clin. Endocrinol. Diabetes 118:113-120(2010) · Mapped (2)

Growth hormone dose in growth hormone-deficient adults is not associated with IGF-1 gene polymorphisms.

Meyer S., Schaefer S., Ivan D., Stolk L., Arp P., Uitterlinden A.G., Nawroth P.P., Plockinger U., Stalla G.K., Tuschy U. et al.

Pharmacogenomics 10:293-302(2009) · Mapped (7)

Association of COLIA1 Sp1 polymorphism with the effect of subcutaneously injected recombinant hGH in GH-deficient adults.

Meyer S., Haist M., Schaefer S., Ivan D., Ittner J.R., Nawroth P.P., Plockinger U., Stalla G.K., Tuschy U., Weber M.M. et al.

Pharmacogenomics 9:1017-1026(2008) · Mapped (13)

Immunohistochemical analysis of VEGF-C/VEGFR-3 system and lymphatic vessel extent in normal and adenomatous human pituitary tissues.

Onofri C., Losa M., Uhl E., Stalla G.K., Renner U.

Exp. Clin. Endocrinol. Diabetes 116:152-157(2008) · Mapped (2)

Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway.

Goncz E., Strowski M.Z., Grotzinger C., Nowak K.W., Kaczmarek P., Sassek M., Mergler S., El-Zayat B.F., Theodoropoulou M., Stalla G.K. et al.

Endocrinology 149:1618-1626(2008) · Mapped (5)

RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.

Carbia-Nagashima A., Gerez J., Perez-Castro C., Paez-Pereda M., Silberstein S., Stalla G.K., Holsboer F., Arzt E.

Cell 131:309-323(2007) · UniProtKB (5) · Mapped (12)

Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.

Schaaf L., Pickel J., Zinner K., Hering U., Hofler M., Goretzki P.E., Spelsberg F., Raue F., von zur Muhlen A., Gerl H. et al.

Exp. Clin. Endocrinol. Diabetes 115:509-517(2007) · Mapped (4)

Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.

Cota D., Steiner M.A., Marsicano G., Cervino C., Herman J.P., Grubler Y., Stalla J., Pasquali R., Lutz B., Stalla G.K. et al.

Endocrinology 148:1574-1581(2007) · Mapped (2)

Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action.

Giacomini D., Paez-Pereda M., Theodoropoulou M., Labeur M., Refojo D., Gerez J., Chervin A., Berner S., Losa M., Buchfelder M. et al.

Endocrinology 147:247-256(2006) · Mapped (11)

Expression and function of sonic hedgehog pathway components in pituitary adenomas: evidence for a direct role in hormone secretion and cell proliferation.

Vila G., Theodoropoulou M., Stalla J., Tonn J.C., Losa M., Renner U., Stalla G.K., Paez-Pereda M.

J. Clin. Endocrinol. Metab. 90:6687-6694(2005) · Mapped (2)

Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly.

Gutt B., Wowra B., Alexandrov R., Uhl E., Schaaf L., Stalla G.K., Schopohl J.

Exp. Clin. Endocrinol. Diabetes 113:219-224(2005) · Mapped (7)

The role of poly (adenosine 5'-diphosphate-ribose) polymerase in the response of pituitary tumor cells to reactive oxygen species.

Newton C.J., Bilko D., Tichomirowa M., Renner U., Stalla G.K.

Endocrinology 146:1119-1127(2005) · Mapped (8)

Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model.

Graciarena M., Carbia-Nagashima A., Onofri C., Perez-Castro C., Giacomini D., Renner U., Stalla G.K., Arzt E.

Eur. J. Endocrinol. 151:595-604(2004) · Mapped (5)

Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3)/cardiotrophin-like cytokine (CLC)--a novel gp130 cytokine with pleiotropic functions.

Vlotides G., Zitzmann K., Stalla G.K., Auernhammer C.J.

Cytokine Growth Factor Rev. 15:325-336(2004) · Mapped (4)

to top of page·

Page of 2 | Next »